Banque Cantonale Vaudoise Has $1.08 Million Position in CME Group Inc. (NASDAQ:CME)

Banque Cantonale Vaudoise cut its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 9.1% during the 3rd quarter, Holdings Channel.com reports. The firm owned 5,384 shares of the financial services provider’s stock after selling 542 shares during the period. Banque Cantonale Vaudoise’s holdings in CME Group were worth $1,077,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CME. Capital Advisors Ltd. LLC grew its stake in shares of CME Group by 5.0% in the third quarter. Capital Advisors Ltd. LLC now owns 1,032 shares of the financial services provider’s stock valued at $207,000 after acquiring an additional 49 shares in the last quarter. West Family Investments Inc. grew its stake in shares of CME Group by 3.4% in the second quarter. West Family Investments Inc. now owns 1,503 shares of the financial services provider’s stock valued at $278,000 after acquiring an additional 50 shares in the last quarter. Glassman Wealth Services grew its stake in shares of CME Group by 11.6% in the second quarter. Glassman Wealth Services now owns 502 shares of the financial services provider’s stock valued at $93,000 after acquiring an additional 52 shares in the last quarter. Fidelis Capital Partners LLC grew its stake in CME Group by 3.9% during the third quarter. Fidelis Capital Partners LLC now owns 1,400 shares of the financial services provider’s stock worth $280,000 after buying an additional 52 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its stake in CME Group by 0.3% during the second quarter. Thrivent Financial for Lutherans now owns 15,841 shares of the financial services provider’s stock worth $3,243,000 after buying an additional 52 shares in the last quarter. 85.69% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 5,560 shares of the firm’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the completion of the transaction, the director now owns 62,452 shares in the company, valued at approximately $13,512,739.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, insider Derek Sammann sold 10,681 shares of CME Group stock in a transaction on Friday, December 1st. The shares were sold at an average price of $220.50, for a total value of $2,355,160.50. Following the completion of the sale, the insider now owns 1,862 shares in the company, valued at approximately $410,571. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 5,560 shares of CME Group stock in a transaction on Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the completion of the sale, the director now owns 62,452 shares of the company’s stock, valued at approximately $13,512,739.24. The disclosure for this sale can be found here. In the last 90 days, insiders sold 18,103 shares of company stock worth $3,971,672. 0.30% of the stock is currently owned by insiders.

CME Group Stock Down 0.8 %

CME Group stock opened at $204.82 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. CME Group Inc. has a 52-week low of $173.42 and a 52-week high of $223.80. The firm has a 50 day moving average price of $208.03 and a two-hundred day moving average price of $207.59. The firm has a market cap of $73.73 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 2.39 and a beta of 0.48.

CME Group Increases Dividend

The company also recently declared a None dividend, which was paid on Thursday, January 18th. Shareholders of record on Thursday, December 28th were issued a dividend of $5.25 per share. This is a positive change from CME Group’s previous None dividend of $4.50. The ex-dividend date of this dividend was Wednesday, December 27th. CME Group’s dividend payout ratio (DPR) is presently 52.51%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CME. Morgan Stanley increased their price objective on shares of CME Group from $215.00 to $220.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 26th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research note on Wednesday, October 11th. The Goldman Sachs Group downgraded shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a research note on Wednesday, January 3rd. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $190.00 to $197.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 11th. Finally, Citigroup raised their price target on shares of CME Group from $215.00 to $240.00 and gave the company a “buy” rating in a research note on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $212.30.

Get Our Latest Stock Analysis on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.